Safety of Gold Nanoparticles

Detalhes bibliográficos
Autor(a) principal: Lopes, Joana
Data de Publicação: 2023
Outros Autores: Ferreira-Gonçalves, Tânia, Ascensão, Lia, Viana, Ana S., Carvalho, Lina, Catarino, José, Faísca, Pedro, Oliva, Abel, de Barros, Dragana P.C., Rodrigues, Cecília M.P., Gaspar, Maria Manuela, Reis, Catarina Pinto
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/158546
Resumo: Funding Information: The authors acknowledge Fundação para a Ciência e a Tecnologia (FCT) for financial support through Projects UIDB/00645/2020, UIDB/04138/2020, UIDP/04138/2020, PTDC/BTM-MAT/31794/2017, and PTDC/QUI-QIN/0586/2020, as well as PhD fellowships SFRH/BD/148044/2019 and SFRH/BD/147306/2019. The authors are also thankful for the financial support to CESAM by FCT/MCTES (UIDP/50017/2020+UIDB/50017/2020+LA/P/0094/2020+UIDB/00100/2020) through national funds. Publisher Copyright: © 2023 by the authors.
id RCAP_a8957ba63793fa4ba0bcee3a00ccb0f9
oai_identifier_str oai:run.unl.pt:10362/158546
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Safety of Gold NanoparticlesFrom In Vitro to In Vivo Testing Array Checklistcancerex vivo modelsgold nanoparticlesin vitro modelsin vivo modelsnanomedicinenanotoxicologyPharmaceutical ScienceSDG 3 - Good Health and Well-beingFunding Information: The authors acknowledge Fundação para a Ciência e a Tecnologia (FCT) for financial support through Projects UIDB/00645/2020, UIDB/04138/2020, UIDP/04138/2020, PTDC/BTM-MAT/31794/2017, and PTDC/QUI-QIN/0586/2020, as well as PhD fellowships SFRH/BD/148044/2019 and SFRH/BD/147306/2019. The authors are also thankful for the financial support to CESAM by FCT/MCTES (UIDP/50017/2020+UIDB/50017/2020+LA/P/0094/2020+UIDB/00100/2020) through national funds. Publisher Copyright: © 2023 by the authors.In recent years, gold nanoparticles (AuNPs) have aroused the interest of many researchers due to their unique physicochemical and optical properties. AuNPs are being explored in a variety of biomedical fields, either in diagnostics or therapy, particularly for localized thermal ablation of cancer cells after light irradiation. Besides the promising therapeutic potential of AuNPs, their safety constitutes a highly important issue for any medicine or medical device. For this reason, in the present work, the production and characterization of physicochemical properties and morphology of AuNPs coated with two different materials (hyaluronic and oleic acids (HAOA) and bovine serum albumin (BSA)) were firstly performed. Based on the above importantly referred issue, the in vitro safety of developed AuNPs was evaluated in healthy keratinocytes, human melanoma, breast, pancreatic and glioblastoma cancer cells, as well as in a three-dimensional human skin model. Ex vivo and in vivo biosafety assays using, respectively, human red blood cells and Artemia salina were also carried out. HAOA-AuNPs were selected for in vivo acute toxicity and biodistribution studies in healthy Balb/c mice. Histopathological analysis showed no significant signs of toxicity for the tested formulations. Overall, several techniques were developed in order to characterize the AuNPs and evaluate their safety. All these results support their use for biomedical applications.Instituto de Tecnologia Química e Biológica António Xavier (ITQB)RUNLopes, JoanaFerreira-Gonçalves, TâniaAscensão, LiaViana, Ana S.Carvalho, LinaCatarino, JoséFaísca, PedroOliva, Abelde Barros, Dragana P.C.Rodrigues, Cecília M.P.Gaspar, Maria ManuelaReis, Catarina Pinto2023-09-30T22:21:49Z2023-042023-04-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/158546eng1999-4923PURE: 72684792https://doi.org/10.3390/pharmaceutics15041120info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:41:06Zoai:run.unl.pt:10362/158546Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:57:12.397244Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Safety of Gold Nanoparticles
From In Vitro to In Vivo Testing Array Checklist
title Safety of Gold Nanoparticles
spellingShingle Safety of Gold Nanoparticles
Lopes, Joana
cancer
ex vivo models
gold nanoparticles
in vitro models
in vivo models
nanomedicine
nanotoxicology
Pharmaceutical Science
SDG 3 - Good Health and Well-being
title_short Safety of Gold Nanoparticles
title_full Safety of Gold Nanoparticles
title_fullStr Safety of Gold Nanoparticles
title_full_unstemmed Safety of Gold Nanoparticles
title_sort Safety of Gold Nanoparticles
author Lopes, Joana
author_facet Lopes, Joana
Ferreira-Gonçalves, Tânia
Ascensão, Lia
Viana, Ana S.
Carvalho, Lina
Catarino, José
Faísca, Pedro
Oliva, Abel
de Barros, Dragana P.C.
Rodrigues, Cecília M.P.
Gaspar, Maria Manuela
Reis, Catarina Pinto
author_role author
author2 Ferreira-Gonçalves, Tânia
Ascensão, Lia
Viana, Ana S.
Carvalho, Lina
Catarino, José
Faísca, Pedro
Oliva, Abel
de Barros, Dragana P.C.
Rodrigues, Cecília M.P.
Gaspar, Maria Manuela
Reis, Catarina Pinto
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Instituto de Tecnologia Química e Biológica António Xavier (ITQB)
RUN
dc.contributor.author.fl_str_mv Lopes, Joana
Ferreira-Gonçalves, Tânia
Ascensão, Lia
Viana, Ana S.
Carvalho, Lina
Catarino, José
Faísca, Pedro
Oliva, Abel
de Barros, Dragana P.C.
Rodrigues, Cecília M.P.
Gaspar, Maria Manuela
Reis, Catarina Pinto
dc.subject.por.fl_str_mv cancer
ex vivo models
gold nanoparticles
in vitro models
in vivo models
nanomedicine
nanotoxicology
Pharmaceutical Science
SDG 3 - Good Health and Well-being
topic cancer
ex vivo models
gold nanoparticles
in vitro models
in vivo models
nanomedicine
nanotoxicology
Pharmaceutical Science
SDG 3 - Good Health and Well-being
description Funding Information: The authors acknowledge Fundação para a Ciência e a Tecnologia (FCT) for financial support through Projects UIDB/00645/2020, UIDB/04138/2020, UIDP/04138/2020, PTDC/BTM-MAT/31794/2017, and PTDC/QUI-QIN/0586/2020, as well as PhD fellowships SFRH/BD/148044/2019 and SFRH/BD/147306/2019. The authors are also thankful for the financial support to CESAM by FCT/MCTES (UIDP/50017/2020+UIDB/50017/2020+LA/P/0094/2020+UIDB/00100/2020) through national funds. Publisher Copyright: © 2023 by the authors.
publishDate 2023
dc.date.none.fl_str_mv 2023-09-30T22:21:49Z
2023-04
2023-04-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/158546
url http://hdl.handle.net/10362/158546
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1999-4923
PURE: 72684792
https://doi.org/10.3390/pharmaceutics15041120
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138155183472640